These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22836066)

  • 1. Statin treatment in patients with elevated liver enzymes: pitch to proceed.
    Berkelhammer C; Lerma EV
    J Clin Lipidol; 2012; 6(4):310-1. PubMed ID: 22836066
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).
    Han KH; Rha SW; Kang HJ; Bae JW; Choi BJ; Choi SY; Gwon HC; Bae JH; Hong BK; Choi DH; Han KR
    J Clin Lipidol; 2012; 6(4):340-51. PubMed ID: 22836071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torcetrapib and atorvastatin.
    Shear CL
    N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16207861
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninferiority of pitavastatin in intravascular ultrasound findings.
    Kaneda H; Ma J; Morita T
    J Am Coll Cardiol; 2010 Jan; 55(3):262-3; author reply 263. PubMed ID: 20117416
    [No Abstract]   [Full Text] [Related]  

  • 5. Statin is a two-edged sword in liver enzyme.
    Li N; Yang YJ
    Int J Cardiol; 2014 Feb; 171(2):e18. PubMed ID: 24360161
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome.
    Uzun M; Yiğiner O; Kirilmaz A
    Turk Kardiyol Dern Ars; 2009 Jul; 37(5):364; author reply 365. PubMed ID: 19875919
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins and altered glucose metabolism: a laboratory curiosity or a new disease?
    Mehta JL
    J Am Coll Cardiol; 2010 Aug; 56(8):680; author reply 680-1. PubMed ID: 20705228
    [No Abstract]   [Full Text] [Related]  

  • 8. Torcetrapib and atorvastatin.
    Hirsch RL
    N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16211711
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin therapy works for patients who have type 2 diabetes.
    Korber KE
    JAAPA; 2008 Oct; 21(10):58, 60. PubMed ID: 19024640
    [No Abstract]   [Full Text] [Related]  

  • 10. Is rosuvastatin really a more efficient therapeutic option than atorvastatin?
    Soto J; Fernandez de Bobadilla J
    Value Health; 2006; 9(4):276-7; author reply 277-9. PubMed ID: 16903999
    [No Abstract]   [Full Text] [Related]  

  • 11. Atorvastatin (Lipitor).
    Tucker G
    Conn Med; 1998 May; 62(5):283-5. PubMed ID: 9639958
    [No Abstract]   [Full Text] [Related]  

  • 12. Torcetrapib and atorvastatin.
    Green AM
    N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16211710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atorvastatin (Lipitor)].
    Carpentier Y; Ducobu J; Sternon J
    Rev Med Brux; 1999 Oct; 20(5):427-33. PubMed ID: 10582478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].
    Takeuchi T; Ota H; Hasebe N
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225
    [No Abstract]   [Full Text] [Related]  

  • 15. Qualitative plaque stabilization but not quantitative plaque regression.
    Nishigaki K
    Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.
    Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R
    Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Help me--I do not tolerate my statin].
    Nater H; Perger L; Suter PM
    Praxis (Bern 1994); 2015 May; 104(10):491-7; quiz 498-9. PubMed ID: 26098050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results from statin trials: answers but more unresolved questions.
    De Backer GG
    Eur Heart J; 2011 Oct; 32(20):2479-80. PubMed ID: 21873709
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E; Sarcinella R
    Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.